News & Press Releases

Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer. 

The M&A landscape in the pharmaceutical industry has shifted significantly since the pandemic. International Life Sciences Chair Cheryl Reicin shares insights in a Pharmaceutical Executive Q&A, discussing the pandemic’s lasting impact on dealmaking trends and the acquisitions poised to gain momentum in 2025.

Of Counsel Michelle Capezza was quoted by Fiduciary News in an article about the potential repercussions of the Johnson v. Parker-Hannifin case over alleged failures to correctly monitor investments, leading to high-cost share classes. Michelle discusses the case’s implications for professional fiduciaries and 401k plan sponsors.

Toronto Office Manager Partner Mitch Frazer was quoted by Benefits Canada in an article about the Canadian federal government’s decision to transfer $1.9 billion surplus from the Public Service Pension Plan to its general revenue. 

Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis – conditions which affect millions worldwide and which currently have few treatments addressing their root causes. 

Mintz advised Greater Asia Pacific, a Hong Kong holding company, in the sale of the controlling interest in Microtek Product Services Co. Ltd. to Centre Testing International Group Co., Ltd. (CTI), a publicly traded Chinese company in the lab tasting space.